PICALM and Alzheimer disease: Additionally, by integrating genomic, transcriptomic, proteomic, and histopathological data, one study reported an increase in human herpesvirus 6A (HHV-6A) in the brains of patients with late-onset AD, which is associated with the interaction between HHV-6A and PICALM [137] (Fig. 3N).